Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.83234 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.47074 | 57 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.90287 | 65 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.03649 | 66 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.69781 | 62 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.92598 | 65 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.82219 | 63 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.7587 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.75261 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.7707 | 63 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.78616 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.93319 | 65 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.79133 | 63 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.78021 | 63 |